(Q43559593)

24 November 2017

Bias in meta-analytic research (English)

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

17 October 2022

1 reference

1 reference

1

1 reference

24 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1624971

17 October 2022

publication date

1 August 1992

1 reference

full work available at URL

24 November 2017

https://api.elsevier.com/content/article/PII:089543569290072U?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

https://api.elsevier.com/content/article/PII:089543569290072U?httpAccept=text/plain

17 October 2022

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Journal of Clinical Epidemiology

17 October 2022

published in

1 reference

24 November 2017

45

1 reference

24 November 2017

885-892

1 reference

24 November 2017

8

1 reference

Meta-analysis in medicine. Where we are and where we want to go.

24 November 2017

1

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials

17 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

17 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Adjuvant chemotherapy for breast cancer. A pooled estimate based on published randomized control trials

17 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Evidence for the Superiority of Immunosuppressive Drugs and Prednisone over Prednisone Alone in Lupus Nephritis

17 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Meta-analyses of randomized controlled trials.

17 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Publication bias: the case for an international registry of clinical trials

17 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Publication bias and dissemination of clinical research.

17 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Publication bias in clinical research

17 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee

17 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Effect of Parenterally Administered Gold Therapy on the Course of Adult Rheumatoid Arthritis

17 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

The file drawer problem and tolerance for null results

17 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

The existence of publication bias and risk factors for its occurrence

17 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews

17 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials.

17 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Perusing the literature. Methods of accessing MEDLINE and related databases

17 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Perusing the literature: comparison of MEDLINE searching with a perinatal trials database

17 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods

17 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

The retrieval of randomized clinical trials in liver diseases from the medical literature: manual versus MEDLARS searches

17 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis

17 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Nonassociation of Adrenocorticosteroid Therapy and Peptic Ulcer

17 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Association of Adrenocorticosteroid Therapy and Peptic-Ulcer Disease

17 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Meta-analysis of clinical trials as a scientific discipline. II: Replicate variability and comparison of studies that agree and disagree

17 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Meta-analysis of psychotherapy outcome studies

17 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses

17 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

Anticoagulants and myocardial infarction. The problems of pooling, drowning, and floating

17 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0895-4356(92)90072-U

17 October 2022

Identifiers

1 reference

24 November 2017

1 reference